SCGC

Shenzhen Capital Group Co., Ltd. (referred to as "Shenzhen Capital Group") was established in 1999 by the Shenzhen Municipal Government with capital contributions and guidance from social capital. The company's mission is to discover and build great enterprises, and it is committed to being an explorer and nurturer of innovative value. It has developed into a comprehensive investment group with venture capital at its core. Its current registered capital is 10 billion yuan, and it manages various funds with a total scale of approximately 464.2 billion yuan. Shenzhen Capital Group currently manages funds including: 179 private equity funds, 16 fund-of-funds, and 20 real estate funds. Additionally, the group has established China's first publicly offered fund management company under a venture capital system — Hongtu Innovation Fund Management Co., Ltd. Centered around its core venture capital business, Shenzhen Capital Group continuously expands the venture capital industry chain, rapidly advancing specialized, diversified, and international operations. In the venture capital business sector, Shenzhen Capital Group primarily invests in small and medium-sized enterprises, self-innovating high-tech enterprises, and emerging industry companies. These cover sectors such as information technology, biotechnology and health, intelligent manufacturing, new energy, new materials, the internet, consumer goods, and modern services, spanning the entire lifecycle of enterprises. The company adheres to the philosophy of "30% investment, 70% service," promoting the rapid and healthy development of invested enterprises through resource integration, capital operations, supervision and standardization, training, and mentoring. As of October 31, 2023, Shenzhen Capital Group leads the industry in the number of invested enterprises and the number of listed invested enterprises: it has invested in 1,734 venture projects (1,453 enterprises), with cumulative investments totaling about 99.6 billion yuan, and exited 543 invested enterprises (including IPOs). Among these, 262 invested enterprises have been listed on 17 global capital markets (excluding the New Third Board). Professional investment and deep service have promoted the growth of numerous star enterprises such as Akeso Biopharma, Yiheda, Tencent Music, Western Superconducting Technologies, CATL, HuaDa Jiutian, Mindray Medical, SICC Materials, BES Technologies, SMIC, Sunway Communication, Raytron Technology, Weichai Power, Fudan Microelectronics, BGI Genomics, Intco Medical, RemeGen, Montage Technology, and Winner Medical, also contributing to Shenzhen Capital Group’s excellent performance. Due to its outstanding performance in the venture capital field, Shenzhen Capital Group has ranked among the top in authoritative rankings organized by institutions such as the China Venture Capital Association, Zero2IPO Group, and CVSource for many consecutive years. From 2016 to 2022, in Zero2IPO's annual ranking of Chinese venture capital institutions, Shenzhen Capital Group ranked first among local venture capital institutions.